Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 2/2009

01-02-2009 | Letter

Improvements in the lifestyle of patients who have had type 1 diabetes for 50 years: an optimistic message

Authors: J.-J. Altman, C. Vincent-Cassy, S. Feldman-Billard

Published in: Diabetologia | Issue 2/2009

Login to get access

Excerpt

To the Editor: The life expectancy of patients with type 1 diabetes continues to improve. Better care has reduced the frequency of organic complications and improved their management. But what is the impact upon quality of life? Two studies, the UK Golden Years cohort [1] and the 50 year Joslin Medalist study [2], have examined the clinical characteristics of type 1 diabetic patients with long disease duration. Here we describe a Parisian cohort and evaluate the lifestyle of patients suffering from this chronic disease for 50 years. …
Literature
1.
Bain SC, Gill GV, Dyer PH et al (2003) Characteristics of type 1 diabetes of over 50 years duration (the Golden Years Cohort). Diabet Med 20:808–811PubMedCrossRef
2.
Keenan HA, Costacou T, Sun JK et al (2007) Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year Medalist study. Diabetes Care 30:1995–1997PubMedCrossRef
3.
Feldman-Billard S, Limon S, Morin Y, Altman JJ (2001) Type 1 diabetes with no diabetic complications, sixty two years later. J Diabetes Complications 15:285–286PubMedCrossRef
4.
Anderson RM (1991) The challenge of translating scientific knowledge into improved diabetes care in the 1990s. Diabetes Care 14:418–421PubMedCrossRef
5.
Qasim A, Rader DJ (2006) Human genetics of variation in high-density lipoprotein cholesterol. Curr Atheroscler Rep 8:198–205PubMedCrossRef
6.
Jonasson JM, Brismar K, Sparén P et al (2007) Fertility in women with type 1 diabetes: a population-based cohort study in Sweden. Diabetes Care 30:2271–2276PubMedCrossRef
7.
EDIC Research Group (1999) Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 22:99–111CrossRef
8.
Gafvels C, Lithner F, Börjeson B (1993) Living with diabetes: relationship to gender, duration and complications. A survey in northern Sweden. Diabet Med 10:768–773PubMedCrossRef
Metadata
Title
Improvements in the lifestyle of patients who have had type 1 diabetes for 50 years: an optimistic message
Authors
J.-J. Altman
C. Vincent-Cassy
S. Feldman-Billard
Publication date
01-02-2009
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 2/2009
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-008-1216-4

Other articles of this Issue 2/2009

Diabetologia 2/2009 Go to the issue

Article

The target cell response to cytokines governs the autoreactive T cell repertoire in the pancreas of NOD mice

Article

Pancreatic adenocarcinoma patients with localised chronic severe pancreatitis show an increased number of single beta cells, without alterations in fractional insulin area

Short Communication

Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderly

Article

Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS)

Article

Metabolic consequences of a 50% partial pancreatectomy in humans

Article

Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits